U.S. markets open in 9 hours 19 minutes
  • S&P Futures

    3,967.50
    +5.50 (+0.14%)
     
  • Dow Futures

    33,896.00
    +39.00 (+0.12%)
     
  • Nasdaq Futures

    11,540.00
    +15.25 (+0.13%)
     
  • Russell 2000 Futures

    1,841.20
    +3.40 (+0.18%)
     
  • Crude Oil

    79.07
    +0.87 (+1.11%)
     
  • Gold

    1,767.70
    +4.00 (+0.23%)
     
  • Silver

    21.27
    +0.07 (+0.33%)
     
  • EUR/USD

    1.0362
    +0.0027 (+0.26%)
     
  • 10-Yr Bond

    3.7480
    +0.0450 (+1.22%)
     
  • Vix

    21.89
    -0.32 (-1.44%)
     
  • GBP/USD

    1.1991
    +0.0041 (+0.34%)
     
  • USD/JPY

    138.5490
    -0.0850 (-0.06%)
     
  • BTC-USD

    16,873.89
    +402.39 (+2.44%)
     
  • CMC Crypto 200

    400.76
    +12.03 (+3.10%)
     
  • FTSE 100

    7,512.00
    +37.98 (+0.51%)
     
  • Nikkei 225

    27,912.47
    -115.37 (-0.41%)
     

ViewRay® to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

DENVER, Sept. 9, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Morgan Stanley 20th Annual Global Healthcare Conference. Scott Drake, President and Chief Executive Officer, and Zach Stassen, Chief Financial Officer, will participate in a fireside chat at 8:00 a.m. Eastern Time on Tuesday, September 13, 2022.

An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at http://investors.viewray.com/events-and-presentations/upcoming-events. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/viewray-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301621041.html

SOURCE ViewRay, Inc.